25 July 2024 in Cell Reports Medicine
Gestational diabetes mellitus (GDM) presents varied manifestations throughout pregnancy and poses a complex clinical challenge. High-depth cell-free DNA (cfDNA) sequencing analysis holds promise in advancing our understanding of GDM pathogenesis and prediction. In 299 women with GDM and 299 matched healthy pregnant women, distinct cfDNA fragment characteristics associated with GDM are identified throughout pregnancy. Integrating cfDNA profiles with lipidomic and single-cell transcriptomic data elucidates functional changes linked to altered lipid metabolism processes in GDM. Transcription start site (TSS) scores in 50 feature genes are used as the cfDNA signature to distinguish GDM cases from controls effectively. Notably, differential coverage of the islet acinar marker gene PRSS1 emerges as a valuable biomarker for GDM. A specialized neural network model is developed, predicting GDM occurrence and validated across two independent cohorts. This research underscores the high-depth cfDNA early prediction and characterization of GDM, offering insights into its molecular underpinnings and potential clinical applications.
7 July 2021 in Frontiers in Endocrinology
We present a 30-year old male presented with hemoptysis as a first manifestation and pulmonary CT scan characteristic of diffuse alveolar hemorrhage. Further abdominal examination discovered a left adrenal mass. Elevated catecholamine and metanephrine levels and subsequent adrenalectomy confirmed the diagnosis of pheochromocytoma. Symptoms of pheochromocytoma are highly variable, which could potentially delay the diagnosis. With careful investigation, emergency medicine practitioners need to be aware of the cunning and changeful manifestations in pheochromocytoma.
12 January 2026 in Research Square
Early-life microbiome development influences somatic growth, yet the role of maternal-to-infant microbial transmission in shaping growth trajectories remains unclear. In a prospective birth cohort of 2,090 mother–infant dyads (13,729 fecal samples, from the first trimester of pregnancy through infancy to 3 years of age), infants were classified into physiological regulation (Trajectory 1), stable (Trajectory 2), and catch-up (Trajectory 3) growth trajectories. We found growth trajectories were significantly associated with maternal microbiome composition before delivery; Bacteroides thetaiotaomicron was enriched in mothers in Trajectory 1 and in their offspring. In contrast, Bifidobacterium pseudocatenulatum exhibited a complex pattern: despite significantly lower maternal abundance and transmission in Trajectory 3, infants in Trajectory 3 displayed comparable or higher abundance by 36 months. Functionally, transmitted B. pseudocatenulatum genomes from Trajectory 3 dyads carried higher counts of glycoside hydrolase and glycosyltransferase genes, which correlated positively with bacterial abundance and offspring somatic growth. Together, we identify a compensatory colonization process in which a limited number of transmitted B. pseudocatenulatum strains with extensive carbohydrate metabolic capacity are selectively retained and amplified.